Credit: doucefleur/Adobe Stock 'We Just Focused on the Factual Record': Kirkland & Ellis Successfully Defends Pharmaceutical Companies in Lipitor MDL
Counsel for Sun Pharmaceutical and Ranbaxy, Devora W. Allon, a partner with Kirkland & Ellis in New York, said that the plaintiffs hired a regulatory expert to say that the Food and Drug Administration moves as fast as it can and that if there had been an earlier target date, the FDA would have met that date.
June 11, 2024 at 02:06 PM
6 minute read
Pharmaceuticals
The original version of this story was published on New Jersey Law Journal
Counsel with Kirkland & Ellis helped Sun Pharmaceutical Industries prevail in its defense of two motions for class certification and on summary judgment in a decadelong antitrust multidistrict litigation over the cholesterol drug Lipitor, where potentially more than $10 billion was at stake.
NOT FOR REPRINT
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Law Firms Mentioned
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2Wine, Dine and Grind (Through the Weekend): Summer Associates Thirst For Experience in 'Real Matters'
- 3'That's Disappointing': Only 11% of MDL Appointments Went to Attorneys of Color in 2023
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
Featured Firms
Law Offices of Gary Martin Hays & Associates, P.C.
(470) 294-1674
Law Offices of Mark E. Salomone
(857) 444-6468
Smith & Hassler
(713) 739-1250
